Home > Healthcare > Medical Devices > Implantable Devices > Coronary Stents Market

Coronary Stents Market Analysis

  • Report ID: GMI2966
  • Published Date: Feb 2023
  • Report Format: PDF

Coronary Stents Market Analysis

Coronary Stents Market Share, By Product

To understand key trends  
Download Free Sample
 

Coronary stents market share from the drug-eluting stent (DES) segment was valued at nearly USD 4.9 billion in 2022. The high growth rate is a result of the benefits of drug-eluting stents, which include better treatment results and a decreased re-obstruction rate, among other things. DES is employed in a variety of applications, including myocardial infarction and percutaneous coronary intervention. The addition of new and advanced drug-eluting stents is expected to fuel product demand.
 

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for coronary stents size was valued at more than USD 5.7 billion in 2022 and is expected to register over 4.5% CAGR from 2023 to 2032.

Cardiac centers segment is expected to witness a 5.1% CAGR between 2023 and 2032 given to a growing patient footfall across these centers.

Asia Pacific coronary stents market is expected to record a 6.2% CAGR during 2023 and 2032 due to the growing geriatric population in the region.

B. Braun Melsungen AG, Elixir Medical Corporation, Boston Scientific Corporation, Abbott Laboratories, Medtronic Plc, and Meril Life Science are some of the key players in the global market.

Coronary Stents Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 270
  • Countries covered: 29
  • Pages: 170
 Download Free Sample